Author:
Qiu Qi,Huang Jing,Shu Xiaoming,Fan Huizheng,Zhou Youwen,Xiao Cheng
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Kung, T. N. et al. RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies. Arthritis Rheumatol 66, 1111–1120 (2014).
2. Li, X. et al. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis. Int Immunopharmacol 38, 8–15 (2016).
3. Owen, S. A. et al. MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms. Pharmacogenomics J 13, 137–147 (2013).
4. Song, G. G., Bae, S. C. & Lee, Y. H. Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Clin Rheumatol 33, 1715–1724 (2014).
5. Y. H. Lee, S.-C. B. & Song, G. G. Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis A meta-analysis. Z Rheumatol, doi: 10.1007/s00393-00015-1618-x (2015).
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献